The ZIKAction Paediatric Registry study has opened. Taking place across sites in Argentina, Brazil and Jamaica. The ZIKAction Paediatric Registry was developed in place of the originally planned prospective paediatric study, once it became clear that the ZIKA virus was circulating less and less at our sites. Several months were dedicated to discussing the new… Read More »
Celia Christie Samuels from the University of West Indies, provided her perspective on COVID-19 in the Caribbean in the recent webinar hosted by the Commonwealth Medical Association on the regional perspectives on clinical case management of COVID-19 , introduced by WHO Director General, Dr Tedros Ghebreyesus on 1 July 2020.
Our primary concern is the safety and wellbeing of all our study participants and those who work within the ZIKAction project. We are working to minimise any additional strain on staff and healthcare system during this time.
The ZikaAction consortium have published a new article titled “Research Zika in Pregnancy: lessons for global preparedness” in the Lancet, infectious diseases.
The ZIKAction Consortium will be presenting preliminary results of its vertical transmission study at the 3rd International Conference on Zika Virus and Aedes related infections that will be held in Washington DC, USA, from 13th to 16th February 2020.
Earlier this month the fourth annual ZIKAction Consortium meeting took place in Guayaquil, Ecuador.
With the 6th issue of the joint ZIKA consortia newsletter we are happy to bring you the latest news about our study on how the project is helping increase the scientific knowledge on the molecular mechanisms behind the trans-placental Zika virus infection.
On 8-9 November the annual ZIKAction Consortium meeting will be held in Guayaquil, Ecuador. Around 40 researchers, health professionals and project managers from partner organizations are planning to participate in the meeting which aims at overviewing the ongoing project studies, their outcomes and setting goals for the upcoming year.
Oct 01, 2019
Knowledge of the molecular mechanisms behind the trans-placental Zika virus infection is one of the most challenging aspects concerning Zika virus congenital disease. Although it is well known that other flaviviruses can occasionally infect the fetus after crossing the placenta, none has the same impact as congenital Zika infection.
We are pleased to bring you the news that ZIKAction partners Fiocruz (Brazil) and University of Oxford (UK) have established a new strategic partnership which will amplify the impact of Fiocruz’s health research and capacity development initiatives by promoting research capacity building across Portuguese-speaking countries, and enabling research findings from the Zika outbreak to benefit public health worldwide.
